NKTX: Nkarta, Inc. Stock

by  •  • Comments Off on NKTX: Nkarta, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 450.99
Enterprise Value ($M) 202.76
Book Value ($M) 473.65
Book Value / Share 3.88
Price / Book 1.65
NCAV ($M) 346.67
NCAV / Share 4.92
Price / NCAV 1.30

Profitability (mra)
Return on Invested Capital (ROIC) -0.32
Return on Assets (ROA) -0.26
Return on Equity (ROE) -0.34

Liquidity (mrq)
Quick Ratio 27.93
Current Ratio 14.54

Balance Sheet (mrq) ($M)
Current Assets 449.95
Assets 576.94
Liabilities 103.28
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -131.65
Net Income -117.50

Cash Flow Statement (mra) ($M)
Cash From Operations -86.16
Cash from Investing 79.02
Cash from Financing 0.69

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-05 13G/A BlackRock Inc. 4.00 8.71
03-29 13D/A Samsara BioCapital, L.P. 5.40 31.38
03-29 13D/A Ra Capital Management, L.p. 18.90 76.81
03-28 13D/A Glaxosmithkline Plc 4.50 0.00
03-28 13D/A New Enterprise Associates 15, L.P. 5.10 0.00
02-09 13D/A LSP 6 Holding C.V. 5.80 30.72
02-07 13G/A Adage Capital Partners Gp, L.l.c. 7.03 -6.76
01-18 13G Boxer Capital, LLC 9.00
11-13 13G/A T. Rowe Price Investment Management, Inc. 0.80 -91.68
10-27 13G Commodore Capital Lp 5.60
10-26 13G Flynn James E 6.93 139.46
10-10 13G/A Wasatch Advisors Inc

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-09 132,225 982,135 13.46
2024-05-08 106,749 598,003 17.85
2024-05-07 104,989 524,210 20.03
2024-05-06 178,723 294,841 60.62

(click for more detail)

Similar Companies
MYGN – Myriad Genetics, Inc. NBIX – Neurocrine Biosciences, Inc.
NEOG – Neogen Corporation NMRA – Neumora Therapeutics, Inc.
NUVL – Nuvalent, Inc.


Financial data and stock pages provided by
Fintel.io